Blog - Page 867 of 889

February 23, 2015April 24, 2018

MARCHON EYEWEAR ANNOUNCES LICENSING AGREEMENT WITH MCM

Marchon Eyewear Inc., one of the world’s largest manufacturers and distributors of quality eyewear and sunwear, and MCM (Modern Creation München), a global manufacturer of luxury leather goods, apparel and footwear, announced today an exclusive global licensing agreement that will grant Marchon the rights to manufacture and distribute the sun and ophthalmic collections under the MCM brand.

The first deliveries will launch in March 2015 with a “Made in Italy” sunwear capsule collection, available exclusively across the MCM worldwide boutique network. The launch represents the beginning of a partnership between these two global players.

The MCM eyewear collection will launch September 2015 in Asia, with a global roll-out planned for January 2016. The eyewear collection will be sold in MCM boutiques, department and specialty stores, and select optical stores worldwide.

For more information visit: www.marchon.com

February 20, 2015April 24, 2018

Prisme Optical Group Welcomes a New US National Sales Manager

Prisme Optical Group has announced the appointment of Guillaume Pottecher as the new United States, National Sales Manager. He will report to Carole Menard, Vice President of Sales.

Guillaume brings 15 years of industry knowledge and established relationships and extensive experience in the high end segment of the optical industry. Guillaume introduced the brand Tag Heuer to the US market and has worked with De Rigo. Guillaume will be responsible for: sales, networking, territory development and training, recruiting qualified representatives, business relations for groups and important key accounts in the US.

Prisme Optical Group is a North American leader in the distribution of high end frames including brands, such as Beausoleil, Oliver Goldsmith Spectacle, Xavier Garcia Barcelona and Tartine & Chocolat.

www.prismeoptical.com

February 20, 2015May 19, 2026

Essilor Reports 12% Revenue Growth in 2014

With revenue up 12% and operations up 15.4%, Essilor maintained its growth in 2014.

Forty-five percent of the French giant’s revenue came from North America. Growth in Canada was supported by Varilux, Crizal, Transitions and Xperio, the impact of the “perfect pair” offer and the company’s widening presence in the mass retailing channel. The introduction of Kodak lenses and the partnership with Riverside Optical labs contributed to expansion in the mid-tier.

Looking beyond the figures, 2014 marked a strategic shift at Essilor. CEO Hubert Sagnières calls the group’s desire to expand its playing field, namely in photochromics, sunwear and online business, a true “cultural revolution.” This strategy was embodied in the acquisitions of Transitions Optical, Coastal.com and Costa, as well as in its collaborative effort with FGX International in a sunglass offering.

February 19, 2015May 19, 2026

One in Four Toronto Homeless Have Vision Problems

A survey by Saint Michael’s Hospital in Toronto found that 25% of homeless people have vision problems, rising to 35% when other eye abnormalities are included. This is four times higher than the North American average.

Of the respondents in need of vision care, 40% would benefit from glasses or contact lenses while 8% required urgent referral to an ophthalmologist. One in three respondents had been previously diagnosed with vision problems.

61 respondents had worn prescription glasses in the past. 43 reported that their glasses had been lost, stolen or broken and could not afford a replacement.

Researchers recommend introducing mobile eye screening centres, which include free eye exams and corrective eyewear. Similar programs have been successful in the United States, the United Kingdom, Costa Rica and South Africa.

Only 14% of those surveyed had visited an ophthalmologist or optometrist within the last year compared with 41% of the general population. 89% of respondents expressed an interest in free eye exams.

For more information: http://www.sciencedaily.com/releases/2015/02/150205123111.htm

February 18, 2015April 24, 2018

A Vaccine Against Eye Cancer

Researchers are currently testing a vaccine that improves the chances of recovery of patients with ocular tumors by stimulating their immune response.

Choroidal melanoma is the most common ocular malignancy. If it is not treated quickly enough, metastases develop and can cause death. Researchers at the University Hospital of Erlangen, Germany, have developed a vaccine to prevent the development of metastases.

Dendritic cells typically trigger the immune response after recognizing a threat. However, in cancer patients, the tumor often blocks the immune response. The new vaccine contains custom dendritic cells and triggers the immune response, which delays or prevents the formation of metastases.

Right now, 200 German patients involved in the study of the vaccine.